Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
Clover Health (Nasdaq: CLOV) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. CEO Andrew Toy will deliver a presentation on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time. Investors and interested parties can access both the live webcast and replay of the presentation and Q&A session through Clover Health's investor relations website at investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV) ha annunciato la sua partecipazione alla 43ª Conferenza Annuale sulla Salute J.P. Morgan. Il CEO Andrew Toy presenterà un intervento mercoledì 15 gennaio 2025, alle 16:30 ora orientale. Gli investitori e le parti interessate possono accedere alla diretta streaming e alla registrazione della presentazione e della sessione di domande e risposte attraverso il sito web delle relazioni con gli investitori di Clover Health su investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV) ha anunciado su participación en la 43ª Conferencia Anual de Salud J.P. Morgan. El CEO Andrew Toy realizará una presentación el miércoles 15 de enero de 2025, a las 4:30 p.m. hora del Este. Los inversores y partes interesadas pueden acceder tanto a la transmisión en vivo como a la repetición de la presentación y la sesión de preguntas y respuestas a través del sitio web de relaciones con los inversores de Clover Health en investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV)는 제43회 J.P. 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO Andrew Toy는 2025년 1월 15일 수요일 오후 4시 30분 동부 표준시에 발표를 진행할 예정입니다. 투자자 및 관심 있는 분들은 Clover Health의 투자자 관계 웹사이트인 investors.cloverhealth.com를 통해 발표 및 질의 응답 세션의 실시간 웨비나와 재생을 모두 접근할 수 있습니다.
Clover Health (Nasdaq: CLOV) a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan sur la Santé. Le CEO Andrew Toy fera une présentation le mercredi 15 janvier 2025, à 16h30 heure de l'Est. Les investisseurs et les parties intéressées peuvent accéder à la transmission en direct ainsi qu'à la rediffusion de la présentation et de la session de questions-réponses via le site Internet des relations investisseurs de Clover Health à investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV) hat die Teilnahme an der 43. jährlichen J.P. Morgan Gesundheitskonferenz angekündigt. CEO Andrew Toy wird am Mittwoch, den 15. Januar 2025, um 16:30 Uhr Eastern Time eine Präsentation halten. Investoren und interessierte Parteien können sowohl auf den Live-Stream als auch auf die Aufzeichnung der Präsentation und der Frage-Antwort-Runde über die Investor-Relations-Website von Clover Health unter investors.cloverhealth.com zugreifen.
- None.
- None.
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time.
A live webcast and replay of the presentation and Q&A session will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
When is Clover Health (CLOV) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Clover Health's (CLOV) J.P. Morgan Healthcare Conference presentation?
Who will represent Clover Health (CLOV) at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference will CLOV be participating in?
